International | Surviving Mesothelioma

Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients

Pleural mesothelioma patients who are recommended for medical thoracoscopy can rest assured that the procedure is “a valuable and safe” diagnostic tool. That is the message from Chinese researchers after an analysis of nine years of medical thoracoscopies on more than 800 patients with malignant mesothelioma and other pleural cancers at a Beijing hospital. What is Medical Thoracoscopy? Medical thoracoscopy is a minimally invasive procedure … Continue reading Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients »

Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival

German surgeons are reporting on a potential new way to improve outcomes for people with malignant pleural mesothelioma by infusing chemotherapy drugs in an isolated area and then removing them. In an article in OncoTargets and Therapy, surgical oncologists from Burghausen, Germany say they were prompted to test the new technique after radical mesothelioma surgery “failed to translate into a definite survival advantage.” Mesothelioma Treatment Risks Although … Continue reading Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival »

The Economic Burden of Malignant Mesothelioma

Patients with malignant mesothelioma and their families are not the only ones impacted by the costs associated with the asbestos-linked cancer. There is also a societal economic burden that can run into the hundreds of millions of dollars. That is the conclusion of a new report published by Canadian occupational medicine and public health experts in the journal Occupational and Environmental Medicine. A History of … Continue reading The Economic Burden of Malignant Mesothelioma »

Malignant Mesothelioma Risk May Eventually Plateau

Mesothelioma Incidence Among Shipbreakers

The risk for developing malignant pleural mesothelioma after asbestos exposure may not increase indefinitely. Researchers in Italy say the chances of contracting the lung-related type of asbestos cancer appear to top out at about 40 years. Unfortunately, the same is not true of peritoneal mesothelioma, which occurs in the abdomen. The risk also continues to increase for lung and ovarian cancer. Cancer Risk from Asbestos … Continue reading Malignant Mesothelioma Risk May Eventually Plateau »

Long-Term Peritoneal Mesothelioma Survival with Apitolisib

There is hopeful news this week about the survivability of peritoneal mesothelioma, particularly when relapses are treated with a powerful drug called apitolisib. Peritoneal mesothelioma is a less common form of the rare asbestos-related cancer, malignant mesothelioma. It starts on the membrane that surround the abdominal organs and can quickly spread throughout the abdomen. According to the National Cancer Institute, the one-year survival rates for … Continue reading Long-Term Peritoneal Mesothelioma Survival with Apitolisib »

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

A large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant mesothelioma has produced some disappointing news. Drug maker AstraZeneca has just released an update on the ongoing DETERMINE trial which suggests that the survival rates are roughly the same for previously-treated mesothelioma patients whether they later received treatment with tremelimumab or a placebo. What is Tremelimumab? … Continue reading Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival »

High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms

High dose radiotherapy may work wonders for some kinds of cancer but it is not recommended as a way to manage the symptoms of pleural mesothelioma. That word comes from a group of mesothelioma experts in one of the world’s mesothelioma hot spots – Melbourne, Australia. Australia has the dubious distinction of having one of the highest rates of malignant mesothelioma in the world due to … Continue reading High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms »

Study to Test New Three-Drug Treatment for Pleural Mesothelioma

The makers of a VEGF-inhibitor called nintedanib are recruiting patients with unresectable pleural mesothelioma for a Phase III clinical trial of the drug in combination with standard chemotherapy. The multicenter trial sponsored by drug maker Boehringer Ingelheim will eventually include a total of 450 mesothelioma patients, but preliminary results from the first 87 patients look promising.  According to data presented at the 2017 American Society of Clinical Oncology … Continue reading Study to Test New Three-Drug Treatment for Pleural Mesothelioma »

BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk

The question of why some asbestos-exposed people develop malignant mesothelioma and others do not has been a key focus of mesothelioma research for more than a decade. We now know that a mutation in the BAP1 gene can predispose certain people to several types of cancer, including mesothelioma. This is known as BAP1 cancer syndrome. Without the BAP1 tumor-suppressing protein to keep it at bay, … Continue reading BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk »

Chamomile Tea May Hold the Secret to Longer Mesothelioma Survival

A new study suggests that a flavonoid found in parsley, celery, and chamomile tea may help improve the odds of surviving malignant mesothelioma. Scientists in Italy have just released some promising findings from tests of the compound apigenin on mesothelioma cells in the lab and in live mice. What is Apigenin? Apigenin is a plant pigment that is part of a larger group of chemicals … Continue reading Chamomile Tea May Hold the Secret to Longer Mesothelioma Survival »

Get your free copy of
“Surviving Mesothelioma” Today!